Treating Addiction With Psychedelics
Psychedelics are being explored for a myriad of neurological and psychiatric conditions. In this video, Technology Networks speak with Professor David Nutt and Anthony Tennyson from Awakn Life Sciences, a Toronto-based company who focus on the use of psychedelics to treat addiction.
Developing Food Testing Techniques To Combat Emerging Contaminants
Food contamination is not a new issue; this is why food producers take care to perform risk assessments and to keep their operations as hygienic as possible. But in recent years, the rise of a new class of contaminants has become a major concern to the industry.
Could COVID-19 Usher in a Digital Future for Healthcare?
Over the last 18 months, the UK National Health Service (NHS) has been hit hard by the COVID-19 pandemic, with nearly 130,000 deaths from COVID-19 recorded. Could a more digitized, data-centric NHS have saved lives? A new study examining how patients were treated over the first wave of the pandemic has shown how machine learning-based methods could transform how standard NHS care is conducted.
Participation in Professional Rugby May Be Linked to Brain Abnormalities
A new study published in Brain Communications suggests that participation in elite adult rugby may be associated with changes in brain structure.
The Brain's Memory Center Is Needed To Recognize Image Sequences
Research shows that the visual cortex stores and remembers individual images, but mice can’t recognize image sequences without guidance from the hippocampus.
New Optogenetic Tool: Light Switches Protein “Off”
A new optogenetic tool, a protein that can be controlled by light, has been characterized by researchers at Ruhr-Universität Bochum (RUB).
Inhaled Nanobodies: A Potential Treatment for COVID-19
Dr. Yi Shi, assistant professor in the department of cell biology at the University of Pittsburgh and colleagues are exploring the potential of nanobodies as a treatment for COVID-19. The team recently published findings from preclinical studies on the use of a nanobody called Pittsburgh inhalable Nanobody-21 (PiN-21) that targets the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein.
Speaking Algae: Tapping the Ancient Power of Microalgae Using Synthetic Biology
How do humans tap into microalgae’s “life experience” to acquire valuable knowledge? To do so, we must learn to speak their “language” and translate that information into useful applications for society and its industries. Amazingly, recent strides in microalgae biotechnology, synthetic biology, and biomanufacturing are making that possible.
Closer Relationships Between Sponsors and Regulators Could Transform Clinical Trials
Both pharmaceutical companies and regulators have collaborated closely over the course of the COVID-19 pandemic to develop vaccines, diagnostic tests and other therapies quicker than ever before and have shown us that clinical development can be accelerated. However, there are still several long-standing barriers to progress, when the focus isn’t on a global pandemic, that must now be remedied.
New Developments in Multiplexing Aim To Reduce Immunoassay Variability
Immunoassays are used for a wide variety of proteomic and genomic applications in drug discovery and development. In this article, we discuss the advantages of multiplexing over single-plex methods and highlight key considerations when developing a multiplex assay.
How To Optimize Next-Generation Sequencing Workflows
Download this guide to learn more about techniques such as bulk tissue RNA sequencing, single-nucleus RNA sequencing and whole-genome DNA sequencing.
Both IHC and ICC are powerful tools that provide insights into gene expression, spatial relationships and biomarker identification in a wide variety of applications. These applications include basic research, assessment of normal and disease states within human and animal tissues and assessment of plant pathology.
Detectors for Gas Chromatography
Gas chromatography (GC) is a technique that enables the separation of compounds of interest present in a gaseous or vaporized sample. Download this listicle to learn about various types of detectors including flame ionization detectors, electron capture detectors and thermal conductivity detectors.
Clinical Omics and Mass Spectrometry
Due to its broad-based applicability to detect compounds with a wide range of masses, along with its high sensitivity, mass spectrometry (MS) has been used extensively in a range of omics analyses and applications. In this listicle, we explore the use of MS-based data in a variety of clinical omics settings.
Drug–Target Binding: Recent Research Developments
Being able to accurately predict drug–target interactions (DTIs) and drug–target binding affinity (DTBA) is crucial in early drug development and during drug repurposing endeavors. Here, we look at some recent research developments in this space.